Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Del Labs

This article was originally published in The Tan Sheet

Executive Summary

Net sales jumped 14.6% to $87.9 mil. in Q2, primarily driven by "continued growth" in Orajel line, cosmetics segment, firm says. Net income for quarter was $3.3 mil., up 74% compared to earnings of $1.9 mil. last year. Six-month sales totaled $160.7 mil., rising 11.4% over prior-year period. Orajel Multi Action Cold Sore Medicine shipped in June, along with new products in Dermarest Psoriasis line; TV ads slated to break in September (1"The Tan Sheet" May 7, p. 5)

You may also be interested in...

Orajel, Dermarest Line Extension Ad Support Slated For September

Del Laboratories will promote its new Orajel Multi Action Cold Sore Medicine by offering a $3 rebate to any consumer who mails the company proof-of-purchase for any cough/cold product.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts